Benefit of Baha in the elderly with single-sided deafness

Faber, Hubert T.; Wolf, Maarten J. F. de; Cremers, C.W.R.J.; Snik, A.F.M.; Hol, Myrthe K. S.

doi:10.1007/s00405-012-2151-z

Cited by 29 publications

(21 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nevertheless, the results of the GBI questionnaires are similar to those obtained with the use of other bone-anchored hearing devices in SSD [Faber et al, 2013;Saroul et al, 2013].…”

Section: Discussionsupporting

confidence: 67%

“…Contralateral rerouting of signal (CROS) hearing aids [Bosman et al, 2003;Finbow et al, 2015;Hol et al, 2005;Wazen et al, 2003] and percutaneous bone-anchored hearing devices [Faber et al, 2013;Martin et al, 2010;Stewart et al, 2011;Zeitler et al, 2012] have been proposed for the rehabilitation of SSD with different results. More recently, cochlear implant has been suggested for the rehabilitation of SSD [Arndt et al, 2011;Erbele et al, 2015;van Zon et al, 2015;Vermeire and Van de Heyning, 2009].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Audiological Results and Quality of Life of Sophono Alpha 2 Transcutaneous Bone-Anchored Implant Users in Single-Sided Deafness

Bernardeschi

Russo

Nguyen³

et al. 2016

Audiol Neurotol

View full text Add to dashboard Cite

Single-sided deafness (SSD) represents one of the most difficult audiological conditions to rehabilitate. The aim of this prospective study was to evaluate the audiological benefits and quality of life of patients affected by SSD who had previously been users of the Alpha 1® when upgrading them to the Sophono Alpha 2® external processor (Boulder, Colo., USA). Nine patients were included in the study. They underwent physical examination, free-field speech audiometry at 40 and 60 dB, a hearing-in-noise test (Hirsch's test and the squelch test), the Glasgow Benefit Inventory (GBI) questionnaire, and a specific questionnaire on patient satisfaction with Alpha 1. Afterwards, the Alpha 2 external processor was delivered to all patients, and the above-mentioned protocol was repeated after 1 month with the Alpha 2. A statistically significant improvement was found in the speech discrimination score at 40 dB and in the squelch test when using the Alpha 2 external processor compared to the Alpha 1. Alpha 2 had a good clinical tolerance and gave similar results in the specific questionnaire and the GBI to Alpha 1. In conclusion, the new Alpha 2 external processor represents a safe and effective device for the rehabilitation of SSD, and there is an audiological benefit to upgrading to the Alpha 2 external processor for patients who had previously been users of the Alpha 1. The improvement in quality of life is similar to that with other bone-anchored hearing devices.

show abstract

“…Nevertheless, the results of the GBI questionnaires are similar to those obtained with the use of other bone-anchored hearing devices in SSD [Faber et al, 2013;Saroul et al, 2013].…”

Section: Discussionsupporting

confidence: 67%

Section: Introductionmentioning

confidence: 99%

Audiological Results and Quality of Life of Sophono Alpha 2 Transcutaneous Bone-Anchored Implant Users in Single-Sided Deafness

Bernardeschi

Russo

Nguyen³

et al. 2016

Audiol Neurotol

View full text Add to dashboard Cite

show abstract

“…There is considerable evidence that SSD users of BAIs consistently display benefit, although performance and subjective outcomes vary [Andersen et al, 2006;Faber et al, 2013]. Benefit, satisfaction, and disability have been shown to be associated with improved performance on SIN tasks [Snapp et al, 2012], and high TA values have been suggested as limiting factors to benefitting by BAI in the SSD population [Stenfelt, 2012].…”

Section: Discussionmentioning

confidence: 99%

“…The benefit of BAIs for SSD has been well documented, but subjective benefit and satisfaction varies considerably [Andersen et al, 2006;Faber et al, 2013]. Despite this, studies regarding candidacy measures and criteria are limited.…”

Section: Introductionmentioning

confidence: 99%

“…The assumption that interaural attenuation for bone conduction is always 0 dB supports that any patient with normal (<20 dB) bone conduction PTA is an optimal candidate for surgery. Despite the well-controlled audiometric criteria for surgery, a high degree of variability in postoperative subjective satisfaction has been demonstrated throughout the literature for individuals with SSD who receive a BAI [Andersen et al, 2006;Faber et al, 2013]. Given that in individuals with SSD the TA is an assumed loss of sensitivity, it is reasonable to presume that TA should be measured and considered in the candidacy and selection process.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Transcranial Attenuation in Patients with Single-Sided Deafness

Snapp

Morgenstein²,

Telischi³

et al. 2016

Audiol Neurotol

View full text Add to dashboard Cite

Transcranial attenuation (TA) of bone-conducted sound has a high degree of variability by frequency and subject, which may play a role in the objective benefit of individuals with single-sided deafness (SSD) treated with a bone-anchored implant (BAI). This study sought to determine whether TA is predictive of benefit in individuals with SSD who receive a BAI. Adult, English-speaking patients with unilateral profound sensorineural hearing loss who underwent a BAI evaluation were included for study. Absolute TA values were consistent with previously published reports. Regression analysis indicated no correlation between TA values and aided speech-in-noise performance for any combined or individual frequencies. Measures of TA do not provide predictive value in determining behavioral outcomes in the SSD population. Specifically, low TA does not suggest improved outcomes with a BAI.

show abstract

Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas

Han

Kim

Chung

et al. 2016

Advances and Technical Standards in Neurosurgery

View full text Add to dashboard Cite

The use of stereotactic radiosurgery (SRS) expanded to include the treatment of vestibular schwannomas (VSs) in 1969; since then, efforts to increase tumour control and to reduce cranial neuropathy have continued. Using the currently recommended marginal dose of 12-13 Gy, long-term reported outcomes after SRS include not only excellent tumour control rates of 92-100 % but also outstanding functional preservation of the trigeminal and facial nerves, with values of 92-100 % and 94-100 %, respectively. Nonetheless, hearing preservation remains in the range of 32-81 %. Previous studies have suggested possible prognostic factors of hearing preservation such as the Gardner-Robertson grade, radiation dose to the cochlea, transient volume expansion (TVE) after SRS, length of irradiated cochlear nerve, marginal dose to the tumour, and age. However, we still do not clearly understand why patients lose their hearing after SRS for VS.Relevant to these considerations, one study recently reported that the auditory brainstem response (ABR) wave V latency and waves I and V interval (IL_I-V) correlated well with intracanalicular pressure values and even with hearing level. The demonstration that ABR values, especially wave V latency and IL_I-V, correlate well with intracanalicular pressure suggests that patients with previously elevated intracanalicular pressure might have an increased chance of hearing loss on development of TVE, which has been recognised as a common phenomenon after SRS or stereotactic radiotherapy (SRT) for intracranial schwannomas.In our experience, the ABR IL_I-V increased during the first 12 months after SRS for VSs in patients who lost their serviceable hearing. The effect of increased ABR IL_I-V on hearing outcome also became significant over time, especially at 12 months after SRS, and was more prominent in patients with poor initial pure-tone average (PTA) and/or ABR values. We hypothesise that patients with considerable intracanalicular pressure at the time of SRS are prone to lose their serviceable hearing due to the added intracanalicular pressure induced by TVE, which usually occurs within the first 12 months after SRS for VSs. Using these findings, we suggested a classification system for the prediction of hearing outcomes after SRS for VSs. This classification system could be useful in the proper selection of management modalities for hearing preservation, especially in patients with only hearing ear schwannoma or neurofibromatosis type 2.Advances in diagnostic tools, treatment modalities, and optimisation of radiosurgical dose have improved clinical outcomes, including tumour control and cranial neuropathies, in patients with VSs. However, the preservation of hearing function still falls short of our expectation. A prediction model for hearing preservation after each treatment modality will guide the proper selection of treatment modalities and permit the appropriate timing of active treatment, which will lead to the preservation of hearing function in patients with VSs.

show abstract

Benefit of Baha in the elderly with single-sided deafness

Cited by 29 publications

References 28 publications

Audiological Results and Quality of Life of Sophono Alpha 2 Transcutaneous Bone-Anchored Implant Users in Single-Sided Deafness

Audiological Results and Quality of Life of Sophono Alpha 2 Transcutaneous Bone-Anchored Implant Users in Single-Sided Deafness

Transcranial Attenuation in Patients with Single-Sided Deafness

Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas

Contact Info

Product

Resources

About